how many doses in 10mg bpc 157 BPC-157 - BPC-157 Dosage Protocol: Injection Guide

In a phase 2 study in people with obesity (without T2D), retatrutide (doses 1 to 12 mg) has led to a dose-dependent WL up to 24.2% at the end of the 48-week treatment period compared to 2.1% with placebo [81]

The fasted state keeps insulin levels low, which allows the peptide to more effectively target fat cells for breakdown

These include numbness, tingling, or difficulty walking

Do not share vials or supplies

This comes shortly after the Company's news release dated July 14, 2026 highlighting that the Company received a 20,000-unit production run of its BPC-157 transdermal patch

In addition, BPC-157 is being investigated in relation to collagen synthesis